 | • レポートコード：QYR9ST03419 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、第VIII因子欠乏症の治療の世界市場について調査・分析し、第VIII因子欠乏症の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血友病A治療薬、血友病A阻害薬治療、フォンウィルブランド病治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の第VIII因子欠乏症の治療市場動向 ・主要企業別マーケットシェア ・第VIII因子欠乏症の治療の種類別市場規模2014-2019 （血友病A治療薬、血友病A阻害薬治療、フォンウィルブランド病治療） ・第VIII因子欠乏症の治療の用途別市場規模2014-2019 （病院、診療所、その他） ・第VIII因子欠乏症の治療の北米市場：主要企業・種類別/用途別市場規模 ・第VIII因子欠乏症の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・第VIII因子欠乏症の治療の中国市場：主要企業・種類別/用途別市場規模 ・第VIII因子欠乏症の治療の日本国内市場：主要企業・種類別/用途別市場規模 ・第VIII因子欠乏症の治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・第VIII因子欠乏症の治療のインド市場：主要企業・種類別/用途別市場規模 ・第VIII因子欠乏症の治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Shire、Bayer HealthCare、CSL、Grifols、Novo Nordisk、F. Hoffmann-La Roche、Kedrion、Octapharma、Biogen Idec、BioMarin Pharmaceutical、Sangamo Therapeutics、Spark Therapeutics、Swedish Orphan Biovitrum、Uniqure NV、Amarna Therapeutics、Dimension Therapeutics） ・第VIII因子欠乏症の治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.The global hemophilia A drugs market segment accounted for the majority market share and will continue to dominate the factor 8 deficiency treatment market for the next few years. Some of the major factors responsible for the market segment’s growth is the growing incidence of hemophilia A, the development of novel drugs with extended action, and the increased adoption of prophylactic treatment. Additionally, growing demand for novel recombinant extended half-life products, the emergence of monoclonal antibodies and gene therapy products, and launch of plasma-derived products for recombinant factor VIII at low costs, will also further drive the growth of the factor VIII deficiency treatment market.
In 2018, the global Factor VIII Deficiency Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Factor VIII Deficiency Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Factor VIII Deficiency Treatment development in United States, Europe and China.
The key players covered in this study
Pfizer
Shire
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics
Market segment by Type, the product can be split into
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Factor VIII Deficiency Treatment status, future forecast, growth opportunity, key market and key players.
To present the Factor VIII Deficiency Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Factor VIII Deficiency Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Hemophilia A Drugs
1.4.3 Hemophilia A Inhibitors Treatment
1.4.4 Von Willebrand Disease Treatment
1.5 Market by Application
1.5.1 Global Factor VIII Deficiency Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Factor VIII Deficiency Treatment Market Size
2.2 Factor VIII Deficiency Treatment Growth Trends by Regions
2.2.1 Factor VIII Deficiency Treatment Market Size by Regions (2014-2025)
2.2.2 Factor VIII Deficiency Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Factor VIII Deficiency Treatment Market Size by Manufacturers
3.1.1 Global Factor VIII Deficiency Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Factor VIII Deficiency Treatment Key Players Head office and Area Served
3.3 Key Players Factor VIII Deficiency Treatment Product/Solution/Service
3.4 Date of Enter into Factor VIII Deficiency Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Factor VIII Deficiency Treatment Market Size by Type (2014-2019)
4.2 Global Factor VIII Deficiency Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Factor VIII Deficiency Treatment Market Size (2014-2019)
5.2 Factor VIII Deficiency Treatment Key Players in United States
5.3 United States Factor VIII Deficiency Treatment Market Size by Type
5.4 United States Factor VIII Deficiency Treatment Market Size by Application
6 Europe
6.1 Europe Factor VIII Deficiency Treatment Market Size (2014-2019)
6.2 Factor VIII Deficiency Treatment Key Players in Europe
6.3 Europe Factor VIII Deficiency Treatment Market Size by Type
6.4 Europe Factor VIII Deficiency Treatment Market Size by Application
7 China
7.1 China Factor VIII Deficiency Treatment Market Size (2014-2019)
7.2 Factor VIII Deficiency Treatment Key Players in China
7.3 China Factor VIII Deficiency Treatment Market Size by Type
7.4 China Factor VIII Deficiency Treatment Market Size by Application
8 Japan
8.1 Japan Factor VIII Deficiency Treatment Market Size (2014-2019)
8.2 Factor VIII Deficiency Treatment Key Players in Japan
8.3 Japan Factor VIII Deficiency Treatment Market Size by Type
8.4 Japan Factor VIII Deficiency Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Factor VIII Deficiency Treatment Market Size (2014-2019)
9.2 Factor VIII Deficiency Treatment Key Players in Southeast Asia
9.3 Southeast Asia Factor VIII Deficiency Treatment Market Size by Type
9.4 Southeast Asia Factor VIII Deficiency Treatment Market Size by Application
10 India
10.1 India Factor VIII Deficiency Treatment Market Size (2014-2019)
10.2 Factor VIII Deficiency Treatment Key Players in India
10.3 India Factor VIII Deficiency Treatment Market Size by Type
10.4 India Factor VIII Deficiency Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Factor VIII Deficiency Treatment Market Size (2014-2019)
11.2 Factor VIII Deficiency Treatment Key Players in Central & South America
11.3 Central & South America Factor VIII Deficiency Treatment Market Size by Type
11.4 Central & South America Factor VIII Deficiency Treatment Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Factor VIII Deficiency Treatment Introduction
12.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Factor VIII Deficiency Treatment Introduction
12.2.4 Shire Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Bayer HealthCare
12.3.1 Bayer HealthCare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Factor VIII Deficiency Treatment Introduction
12.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.3.5 Bayer HealthCare Recent Development
12.4 CSL
12.4.1 CSL Company Details
12.4.2 Company Description and Business Overview
12.4.3 Factor VIII Deficiency Treatment Introduction
12.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.4.5 CSL Recent Development
12.5 Grifols
12.5.1 Grifols Company Details
12.5.2 Company Description and Business Overview
12.5.3 Factor VIII Deficiency Treatment Introduction
12.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.5.5 Grifols Recent Development
12.6 Novo Nordisk
12.6.1 Novo Nordisk Company Details
12.6.2 Company Description and Business Overview
12.6.3 Factor VIII Deficiency Treatment Introduction
12.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.6.5 Novo Nordisk Recent Development
12.7 F. Hoffmann-La Roche
12.7.1 F. Hoffmann-La Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Factor VIII Deficiency Treatment Introduction
12.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.7.5 F. Hoffmann-La Roche Recent Development
12.8 Kedrion
12.8.1 Kedrion Company Details
12.8.2 Company Description and Business Overview
12.8.3 Factor VIII Deficiency Treatment Introduction
12.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.8.5 Kedrion Recent Development
12.9 Octapharma
12.9.1 Octapharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Factor VIII Deficiency Treatment Introduction
12.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.9.5 Octapharma Recent Development
12.10 Biogen Idec
12.10.1 Biogen Idec Company Details
12.10.2 Company Description and Business Overview
12.10.3 Factor VIII Deficiency Treatment Introduction
12.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2014-2019)
12.10.5 Biogen Idec Recent Development
12.11 BioMarin Pharmaceutical
12.12 Sangamo Therapeutics
12.13 Spark Therapeutics
12.14 Swedish Orphan Biovitrum
12.15 Uniqure NV
12.16 Amarna Therapeutics
12.17 Dimension Therapeutics
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Factor VIII Deficiency Treatment Key Market Segments
Table Key Players Factor VIII Deficiency Treatment Covered
Table Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Factor VIII Deficiency Treatment Market Size Market Share by Type 2014-2025
Figure Hemophilia A Drugs Figures
Table Key Players of Hemophilia A Drugs
Figure Hemophilia A Inhibitors Treatment Figures
Table Key Players of Hemophilia A Inhibitors Treatment
Figure Von Willebrand Disease Treatment Figures
Table Key Players of Von Willebrand Disease Treatment
Table Global Factor VIII Deficiency Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Factor VIII Deficiency Treatment Report Years Considered
Table Global Factor VIII Deficiency Treatment Market Size 2014-2025 (Million US$)
Figure Global Factor VIII Deficiency Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Factor VIII Deficiency Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Factor VIII Deficiency Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Factor VIII Deficiency Treatment Market Share by Regions 2014-2019
Figure Global Factor VIII Deficiency Treatment Market Share by Regions 2014-2019
Figure Global Factor VIII Deficiency Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Factor VIII Deficiency Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Factor VIII Deficiency Treatment Market Share by Manufacturers (2014-2019)
Figure Global Factor VIII Deficiency Treatment Market Share by Manufacturers in 2018
Table Global Factor VIII Deficiency Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Factor VIII Deficiency Treatment Product/Solution/Service
Table Date of Enter into Factor VIII Deficiency Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Factor VIII Deficiency Treatment Market Size Share by Type (2014-2019)
Figure Global Factor VIII Deficiency Treatment Market Size Market Share by Type (2014-2019)
Table Global Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Factor VIII Deficiency Treatment Market Size Share by Application (2014-2019)
Figure Global Factor VIII Deficiency Treatment Market Size Market Share by Application (2014-2019)
Figure Global Factor VIII Deficiency Treatment Revenue Market Share by Application in 2018
Figure United States Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table United States Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table United States Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Figure Europe Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table Europe Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table Europe Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Figure China Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table China Factor VIII Deficiency Treatment Market Size by Type (2014-20189) (Million US$)
Table China Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table China Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table China Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Figure Japan Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table Japan Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table Japan Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table Southeast Asia Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table Southeast Asia Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Figure India Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table India Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table India Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table India Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table India Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Figure Central & South America Factor VIII Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Factor VIII Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Factor VIII Deficiency Treatment Market Share (2018-2019)
Table Central & South America Factor VIII Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Factor VIII Deficiency Treatment Market Share by Type (2014-2019)
Table Central & South America Factor VIII Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Factor VIII Deficiency Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Factor VIII Deficiency Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Shire Company Details
Table Shire Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Shire Recent Development
Table Bayer HealthCare Company Details
Table Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Bayer HealthCare Recent Development
Table CSL Company Details
Table CSL Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table CSL Recent Development
Table Grifols Company Details
Table Grifols Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Grifols Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Novo Nordisk Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Kedrion Company Details
Table Kedrion Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Kedrion Recent Development
Table Octapharma Company Details
Table Octapharma Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Octapharma Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2014-2019)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2014-2019)
Table Biogen Idec Recent Development
Table BioMarin Pharmaceutical Company Details
Table Sangamo Therapeutics Company Details
Table Spark Therapeutics Company Details
Table Swedish Orphan Biovitrum Company Details
Table Uniqure NV Company Details
Table Amarna Therapeutics Company Details
Table Dimension Therapeutics Company Details
Table Global Factor VIII Deficiency Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Factor VIII Deficiency Treatment Market Size Share by Regions (2019-2025)
Figure Global Factor VIII Deficiency Treatment Market Size Share by Regions in 2025
Figure United States Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Factor VIII Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Factor VIII Deficiency Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Factor VIII Deficiency Treatment Market Size by Product (2019-2025)
Figure Global Factor VIII Deficiency Treatment Market Size by Product in 2025
Table Global Factor VIII Deficiency Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Factor VIII Deficiency Treatment Market Size by Application (2019-2025)
Figure Global Factor VIII Deficiency Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
因子IX欠乏症の治療の世界市場：市場規模・現状・予測 Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market duri…- 成長ホルモン欠乏症治療の世界市場：市場規模・現状・予測 Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction.The primary factor contributing to the growth of global growth hormone deficien…
- 血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 感染症治療の世界市場：市場規模・現状・予測 Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.In 2018, the global Infectious Disease Treatment market size was xx …
- パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA)…